je.st
news
Tag: findings
Findings Across a Range of Hematological Cancers Add to The Growing Breadth of KEYTRUDA (pembrolizumab) Data
2015-12-08 14:00:00| Merck.com - Product News
Dateline City: KENILWORTH, N.J. New Findings Presented at 57th American Society of Hematology Annual Meeting in Difficult-to-Treat Blood Cancers Including Multiple Myeloma and Three Types of Lymphoma Broad KEYTRUDA Development Program in Hematology Includes Four Registrational Studies KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today that new study findings investigating the use of KEYTRUDA (pembrolizumab), the companys anti-PD-1 therapy, across a range of hematological cancers were presented at the 57th American Society of Hematology (ASH) Annual Meeting. Language: English Contact: MerckMedia:Pamela Eisele, 267-305-3558Kim Hamilton, 908-391-0131orInvestors:Teri Loxam, 908-740-1986Justin Holko, 908-740-1879 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Pearl District | 12-4-15 | 425-431 NW 9th Ave | Design Review w/ Modifications & Adjustments - FINAL FINDINGS| LU 15-209365 DZM AD
2015-12-04 18:08:34| PortlandOnline
PDF Document, 5,215kbCategory: Neighbors West/Northwest Decisions
Final Findings & Decision by the Historic Landmarks Commission - November 24, 2015
2015-12-02 20:56:46| PortlandOnline
PDF Document, 3,106kbCategory: Type IV Demolition Review
Tags: november
final
decision
commission
Buckman | 11-30-15 | SE Stark St between SE 11th Ave and 12th Ave | Design Review w/ Modifications - FINAL FINDINGS | LU 15-208454 DZM
2015-11-30 23:26:57| PortlandOnline
PDF Document, 3,697kbCategory: Southeast Uplift Neighborhood Program Decisions
Historic Landmarks Commission Final Findings & Decision - November 9, 2015
2015-11-30 19:38:48| PortlandOnline
PDF Document, 3,106kbCategory: Type III Historic Review
Tags: november
final
decision
commission
Sites : [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] next »